Angel Biotechnology Holdings Plc is a public limited company registered in England and Wales, registration number 05383314, registered office 50 Broadway, London SW1H OBL, United Kingdom.
Angel Biotechnology Holdings Plc was admitted to trading on AIM in November 2005 under ticker ABH. Angel is not traded on any other platform than AIM.
Identity and percentage holding of shareholders with greater than 3% holding:
|TD Direct Investing Nominees (Europe) Ltd||478,344,064||13.4%|
|Barclayshare Nominees Ltd||381,344,037||10.7%|
|Hargreave Hale Nominees Ltd||267,800,000||7.5%|
|Chase Nominees Ltd||250,000,000||7.0%|
|HSDL Nominees Ltd||224,041,940||6.3%|
|Investor Nominees Ltd||169,195,164||4.7%|
|James Capel (Nominees) Ltd||161,761,888||4.5%|
|L R Nominees Ltd||144,563,154||4.0%|
|Hargreaves Lansdown (Nominees) Ltd||142,428,343||4.0%|
Ordinary shares in issue: 3,773,616,615
Information correct at 25 April 2012.
Angel Biotechnology Holdings Plc, (AIM: ABH), the biopharmaceutical contract manufacturer, announces that application has been made for the admission to trade on AIM of 4,803,573 ordinary shares of 0.1p ("ordinary shares") nominal value with admission expected to take place on 13 April 2011.
PLC registered office
Baker Tilly UK Audit LLP
Bircham Dyson Bell
Grant Thornton UK LLP